179 related articles for article (PubMed ID: 10898829)
1. Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid.
Lebwohl M
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S43-6. PubMed ID: 10898829
[TBL] [Abstract][Full Text] [Related]
2. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.
Lebwohl MG; Breneman DL; Goffe BS; Grossman JR; Ling MR; Milbauer J; Pincus SH; Sibbald RG; Swinyer LJ; Weinstein GD; Lew-Kaya DA; Lue JC; Gibson JR; Sefton J
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):590-6. PubMed ID: 9777766
[TBL] [Abstract][Full Text] [Related]
3. Tazarotene combination treatments in psoriasis.
Guenther L
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S36-42. PubMed ID: 10898828
[TBL] [Abstract][Full Text] [Related]
4. A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis.
Green L; Sadoff W
J Cutan Med Surg; 2002; 6(2):95-102. PubMed ID: 11992180
[TBL] [Abstract][Full Text] [Related]
5. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
Poulin YP
Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
[TBL] [Abstract][Full Text] [Related]
6. Optimizing treatment with topical tazarotene.
Guenther LC
Am J Clin Dermatol; 2003; 4(3):197-202. PubMed ID: 12627995
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety of tazarotene: optimizing clinical results.
Lebwohl M
Cutis; 1998 Feb; 61(2 Suppl):27-9. PubMed ID: 9787989
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis.
Gollnick H; Menter A
Br J Dermatol; 1999 Apr; 140 Suppl 54():18-23. PubMed ID: 10731130
[TBL] [Abstract][Full Text] [Related]
9. Tazarotene in combination with topical corticosteroids.
Lebwohl M; Poulin Y
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S139-43. PubMed ID: 9777792
[TBL] [Abstract][Full Text] [Related]
10. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis.
Sugarman JL; Gold LS; Lebwohl MG; Pariser DM; Alexander BJ; Pillai R
J Drugs Dermatol; 2017 Mar; 16(3):197-204. PubMed ID: 28301614
[TBL] [Abstract][Full Text] [Related]
11. Topical tazarotene: a review of its use in the treatment of plaque psoriasis.
Dando TM; Wellington K
Am J Clin Dermatol; 2005; 6(4):255-72. PubMed ID: 16060713
[TBL] [Abstract][Full Text] [Related]
12. Tazarotene Revisited: Safety and Efficacy in Plaque Psoriasis and Its Emerging Role in Treatment Strategy.
Tanghetti E; Lebwohl M; Stein Gold L
J Drugs Dermatol; 2018 Dec; 17(12):1280-1287. PubMed ID: 30586259
[TBL] [Abstract][Full Text] [Related]
13. An observation study evaluating the treatment of plaque psoriasis with tazarotene gels, alone and with an emollient and/or corticosteroid.
Tanghetti EA;
Cutis; 2000 Dec; 66(6 Suppl):4-11. PubMed ID: 11147088
[TBL] [Abstract][Full Text] [Related]
14. Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapies.
Endzweig-Gribetz CH; Brady C; Lynde C; Sibbald D; Lebwohl M
J Cutan Med Surg; 2002; 6(3 Suppl):12-6. PubMed ID: 11976987
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics of tazarotene and acitretin in psoriasis.
Heath MS; Sahni DR; Curry ZA; Feldman SR
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):919-927. PubMed ID: 30134735
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and safety of tazarotene.
Menter A
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S31-5. PubMed ID: 10898827
[TBL] [Abstract][Full Text] [Related]
17. Topical tazarotene vs. coal tar in stable plaque psoriasis.
Kumar U; Kaur I; Dogra S; De D; Kumar B
Clin Exp Dermatol; 2010 Jul; 35(5):482-6. PubMed ID: 19874376
[TBL] [Abstract][Full Text] [Related]
18. DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion for Topical Use: A Newly Approved Combination Corticosteroid and Retinoid Topical Treatment of Plaque Psoriasis in Adults.
Gupta AK; Love RP; Abramovits W; Vincent KD
Skinmed; 2019; 17(3):181-183. PubMed ID: 31496472
[No Abstract] [Full Text] [Related]
19. Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis.
Weinstein GD
Br J Dermatol; 1996 Oct; 135 Suppl 49():32-6. PubMed ID: 9035703
[TBL] [Abstract][Full Text] [Related]
20. Tazarotene gel: efficacy and safety in plaque psoriasis.
Weinstein GD
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S33-8. PubMed ID: 9270554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
